Skip to content
WELCOME10 — 10% OFF YOUR FIRST ORDER  ·  FREE SHIPPING OVER $300 CAD  ·  COA ON EVERY ORDER
Research Comparison

Ipamorelin vs Retatrutide

Ipamorelin and Retatrutide are studied in overlapping research areas, which is why they are frequently compared. This is a neutral side-by-side reference drawn from published preclinical literature and laboratory handling data.

Shared research areas:Metabolic
ClassSynthetic pentapeptide GH secretagogue (ghrelin-receptor agonist)Lipidated single-chain triple receptor agonist (GIP / GLP-1 / glucagon)
Molecular weight711.85 g/mol4759.5 g/mol
CAS numberNot assigned / not specifiedNot assigned / not specified
Purity spec≥97%≥99%
Research areasHormonal & Endocrine, MetabolicMetabolic
Primary diluentBacteriostatic water (0.9% benzyl alcohol)Bacteriostatic water (0.9% benzyl alcohol)
Working windowCommonly worked with for 3-4 weeks at 2-8 °C — helped by the absence of oxidation-prone residues.Commonly worked with for 4–6 weeks at 2–8 °C.
Lead degradation routeC-terminal amide hydrolysis over long solution storage.Interfacial aggregation from agitation, foaming, or freeze–thaw — the primary practical failure mode for this molecule class.
Freeze–thawTolerates freezing reasonably; aliquot on first reconstitution as standard practice.Avoid freezing reconstituted material. For lipidated peptides the freeze–thaw risk is aggregation at the ice–liquid interface rather than chemical breakdown, and aggregation is not reversible on rewarming.
Light sensitivityNo specific light requirement beyond normal practice.No specific light requirement beyond normal practice.

How they actually differ

Comparing the two: Ipamorelin is synthetic pentapeptide gh secretagogue (ghrelin-receptor agonist), while Retatrutide is lipidated single-chain triple receptor agonist (gip / glp-1 / glucagon) — different molecular classes with different handling consequences; their leading degradation routes differ (c-terminal amide hydrolysis over long solution storage. for Ipamorelin, interfacial aggregation from agitation, foaming, or freeze–thaw for Retatrutide), so the storage precautions that matter are not the same; their practical working windows differ once reconstituted. The sections below set out each in full.

Ipamorelin — origin

Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) is a pentapeptide ghrelin-receptor agonist. It was characterised as the first highly selective growth-hormone secretagogue — prompting GH release with minimal effect on cortisol, prolactin or appetite signalling, which is the property that keeps it in the research literature.

Retatrutide — origin

Retatrutide is a rationally engineered single peptide chain designed to activate three receptors at once — GIP, GLP-1, and glucagon. It represents the third generation of incretin design: mono-agonists first, dual agonists such as tirzepatide second, and triagonists third. Adding glucagon-receptor activity is the conceptual leap, since glucagon signalling contributes energy expenditure rather than only appetite and glycaemic effects.

Ipamorelin research themes

Ghrelin-receptor selectivity

Studied as a selective GHS-R agonist that releases GH with little effect on cortisol, prolactin or ACTH — the feature that distinguishes it from earlier GHRPs.

GH pulsatility

Examined for the shape and timing of growth-hormone release in research models.

Complementary pairing

Frequently combined with GHRH analogues such as CJC-1295 to study two GH-release pathways at once.

Retatrutide research themes

Triple receptor engagement

The defining feature: simultaneous GIP, GLP-1, and glucagon receptor activity from one chain.

Energy expenditure

Glucagon-receptor activity is studied for its contribution to energy expenditure, distinguishing triagonists from dual agonists.

Glucose regulation

Investigated in metabolic research models for effects on glucose homeostasis.

Body composition in research models

A major focus of the preclinical literature on this compound class.

Ipamorelin handling

  • Reach room temperature before opening.
  • Swirl to dissolve; the peptide clears in seconds.
  • Label aliquots with reconstitution date and diluent.

Retatrutide handling

  • Never shake. Foam on a lipidated peptide solution is denatured material at the air–liquid interface, not a cosmetic issue.
  • Introduce diluent slowly down the vial wall and allow the cake to dissolve without agitation, which may take several minutes.
  • Do not freeze reconstituted solution — aggregation from freeze–thaw is irreversible.
  • Faint opalescence at high concentration is expected; visible particulate is not.

Both third-party tested

Every Popular Peptides batch of Ipamorelin and Retatrutide is independently tested by HPLC and LC-MS with a published Certificate of Analysis. Enter a lot number to pull the COA for a specific vial.

Verify a batchPublished COAsHow we test

Ipamorelin reference

Full Ipamorelin reference Ipamorelin storage Ipamorelin reconstitution Ipamorelin calculatorIpamorelin product details

Retatrutide reference

Full Retatrutide reference Retatrutide storage Retatrutide reconstitution Retatrutide calculatorRetatrutide product details

Related comparisons

5-Amino-1MQ vs Ipamorelin5-Amino-1MQ vs RetatrutideCJC-1295 (No DAC) vs IpamorelinCJC-1295 (No DAC) vs RetatrutideCJC-1295 + Ipamorelin vs IpamorelinCJC-1295 + Ipamorelin vs RetatrutideIGF-1 LR3 vs IpamorelinIGF-1 LR3 vs Retatrutide

Ipamorelin and Retatrutide are supplied strictly as research chemicals for in-vitro laboratory and research use only. They are not intended for human or animal consumption, diagnostic, or therapeutic use. This comparison summarizes published preclinical literature and laboratory handling data; it is not medical advice, not a claim of efficacy, and not usage guidance.